Stock Events

Stock Events

Search...

Fate Therapeutics (FATE) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.59

-0.54

-0.5

-0.45

Details

Expected EPS

-0.471778

Actual EPS

-0.47

Surprise EPS

0

Surprise Percent

+0.38%

Description

Fate Therapeutics (FATE) has reported earnings of -0.47 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.